Clinical Trial Update: Treat-and-resect Study of Echo Decorrelation Imaging-controlled Radiofrequency Ablation in Liver Tumors [NA]

View source ↗

Summary

The treat-and-resect study of Echo Decorrelation Imaging–controlled Radiofrequency Ablation for liver tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Snippet

Sponsor: University of Cincinnati | Conditions: Liver Tumor | NA | Status: WITHDRAWN